1,035 results on '"Inwards, David J."'
Search Results
102. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
103. Lenalidomide/RCHOP (R2CHOP) Produces High Response Rates and Overall Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma- Results from MC078E
104. Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study
105. Quality of Life after Diagnosis in Survivors of Aggressive Lymphomas
106. Impact of Cell of Origin (COO) on Long Term Outcomes Post Autologous Hematopoietic Cell Transplant in Patients with Relapsed/ Refractory Chemotherapy Sensitive De-Novo Diffuse Large B-Cell Lymphoma (DLBCL)
107. Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)
108. Waldenström Macroglobulinemia in the Very Elderly (≥75 years):Clinical Characteristics and Outcomes
109. Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation
110. Predictors of short-term survival in Waldenström Macroglobulinemia
111. Outcomes in Primary CNS Lymphoma Post BEAM Autologous Stem Cell Transplantation: A Single-Center Analysis.
112. Outcomes of Adult Burkitt Lymphoma Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) in CR1 Versus ≥ CR2 - a Single Institution Retrospective Analysis
113. Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio
114. A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
115. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma
116. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma
117. Low-Dose, Single-Agent Temsirolimus for Relapsed Mantle Cell Lymphoma: A Phase 2 Trial in the North Central Cancer Treatment Group
118. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation
119. Long-Term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-Cda) Alone (95-80-53) Or 2-Cda and Rituximab (N0189) in the North Central Cancer Treatment Group
120. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
121. Host Genetic Variation in the TNF and NF-ĸB Pathways and Overall Survival in Mantle Cell Lymphoma: A Discovery and Replication Study
122. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas
123. AMD3100 Affects Autograft Lymphocyte Collection and Progression-Free Survival After Autologous Stem Cell Transplantion in Non-Hodgkin Lymphoma
124. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma
125. Combined positron emission tomography/computed tomography for evaluation of presumed choroidal metastases
126. Absolute lymphocyte count predicts overall survival in follicular lymphomas
127. Response to Rituximab in Patients with Type II Cryoglobulinemia
128. Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma
129. Primary Lymphomas of Bone
130. Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma
131. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
132. How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults
133. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
134. Therapeutic Options in Patients With Lymphoma and Severe Liver Dysfunction
135. Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary Review
136. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease
137. Stem cell transplantation for the management of primary systemic amyloidosis
138. Fatal Disseminated Aspergillosis following Sequential Heart and Stem Cell Transplantation for Systemic Amyloidosis
139. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
140. Acquired C1 Esterase Inhibitor Deficiency
141. A Randomized, Placebo-Controlled Study of Outpatient Premedication for Bone Marrow Biopsy in Adults with Lymphoma
142. Testicular lymphoma is associated with a high incidence of extranodal recurrence
143. Spontaneous Remission of Anemia Associated with a Myelodysplastic Syndrome with Disease Evolution into a Myeloproliferative State
144. Central Nervous System Involvement in Peripheral T-Cell Lymphoma
145. Waldenström Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
146. Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era
147. Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
148. Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation
149. Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
150. Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.